Skip to content

Vera Therapeutics VERA Other Non-Current Liabilities

Other Non-Current Liabilities at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$1.26B+31.9%
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
$9.38M+28.9%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$6.9M-39.5%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$8.45M+25.0%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$2.18M+15.5%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$19.42M+31.1%

Other financials

Income statement

See full
Operating income-$125.1M-119%
Net income-$121.0M-134%
EPS (diluted)-$1.69-109%

Balance sheet

See full
Cash & equivalents$114.4M+108%
Total debt$75.0M+37.8%
Total equity$499.7M-6.6%
Total assets$621.7M+1.9%

Cash flow

See full
Operating cash flow-$106.5M-95.8%
CapEx$23.0K-87.7%
Free cash flow-$106.5M-95.1%

Valuation

See full
Market cap$2.74B+87.5%
Enterprise value$2.7B+85.0%

Returns & leverage

See full
Return on equity-71.3%+296pp
Debt / equity0.2×0.0×
Current ratio13.6×-14.0×

Where this comes from

Reported directly by Vera Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.

The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vera Therapeutics's other non-current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vera Therapeutics's other non-current liabilities?
Vera Therapeutics (VERA) reported other non-current liabilities of $1.86M in Q1 2026.
What does other non-current liabilities mean?
Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.